Blog
RSS FeedPosted by Michael Wonder on 25 Nov 2021
Medicines Australia welcomes tabling of parliamentary report about approval processes for new drugs and novel medical technologies
25 November 2021 - Medicines Australia welcomes the House of Representatives Health, Aged Care and Sport Committee Inquiry report into ...
Posted by Michael Wonder on 11 Oct 2021
Review of the National Medicines Policy
11 October 2021 - The call for submissions closed on Friday 8 October 2021 and a total of 107 submissions have ...
Posted by Michael Wonder on 30 Aug 2021
Review of the National Medicines Policy – call for submissions
30 August 2021 - The National Medicines Policy Review Committee is now welcoming submissions to support the review of the National Medicines ...
Posted by Michael Wonder on 03 Aug 2021
National Medicines Policy Review Committee and Terms of Reference
3 August 2021 - The National Medicines Policy has influenced a number of important strategies, frameworks and programs developed since ...
Posted by Michael Wonder on 02 Aug 2021
National Medicines Policy Review will be significant for all Australians
30 July 2021 - Medicines Australia is eager to be part of a significant moment in history for Australian health ...
Posted by Michael Wonder on 30 Jul 2021
Announcement of the National Medicines Policy Review Committee and Terms of Reference
30 August 2021 - The Minister for Health has established an Expert Advisory Committee to lead the Review of the National ...
Posted by Michael Wonder on 24 Jun 2021
National Medicines Policy review to begin in August 2021
24 June 2021 - The review of the National Medicines Policy will begin in August 2021. ...
Posted by Michael Wonder on 30 Apr 2021
Cancer expert to head review into efficient and equitable access to chemotherapy medicines
1 May 2021 - Renowned cancer expert Professor Sanchia Aranda AM will head an Australian Government review aimed at making ...
Posted by Michael Wonder on 11 Oct 2020
Integrative review of managed entry agreements: chances and limitations
10 October 2020 - Managed entry agreements consist of a set of instruments to reduce the uncertainty and the budget impact ...
Posted by Michael Wonder on 21 Apr 2020
Pharmacists welcome medicine review update
21 April 2020 - Elderly people at risk of medicine-related harm will now have their treatments more regularly reviewed by ...
Posted by Michael Wonder on 08 Jan 2020
PBAC – 2019 in review
8 January 2020 - The PBAC considered 188 submissions in 2019. ...
Posted by Michael Wonder on 18 Nov 2019
Biostatistics: a fundamental discipline at the core of modern health data science
28 October 2019 - The value of our health and medical research investment is at risk unless we foster the discipline ...
Posted by Michael Wonder on 09 Oct 2019
High health care costs suggest review is needed: report
8 October 2019 - The federal government’s annual $6 billion spend on the health insurance rebate could be redirected to ...
Posted by Michael Wonder on 22 Jul 2019
Australia's National Medicines Policy is outdated and in need of review
22 July 2019 - How will issues such as disruptive innovation, precision medicine and climate change affect Australia's medicines policy ...
Posted by Michael Wonder on 08 Jul 2019
Pharma giant wants vaccination reform
9 July 2019 - Pharmaceutical giant GSK is calling for Australia to update its review of subsidised immunisation programs and ...